GCI has taken on GlaxoSmithKline's Alan Archer as head of
Archer, currently gsk head of international pharmaceutical
communications, takes up the post of CEO of GCI Healthcare in UK and
Europe at the end of this month.
He is the first divisional head since the departure last August of
Catherine Warne, who left to set up medical specialist agency Red Door
Since Warne's departure, the division, which had solely concentrated on
ethical PR, has absorbed Maureen Cropper Communications, to include
The division has been jointly run by Maureen Cropper as MD of OTC and
Rachel Terry, MD of ethical, since September last year.
Archer heads a 30-strong team and reports to Adrian Wheeler, GCI UK's
Wheeler said: 'We needed someone to co-ordinate both areas and so have
brought someone of Alan's experience and knowledge on board.'
One of Archer's first tasks will be to set up a specialist biotechnology
Archer had been director of corporate communications with SmithKline
Beecham before it merged with GlaxoWellcome earlier this year.
He will be replaced at gsk by the promotion of Louise Sibley, currently
head of communications for consumer healthcare worldwide.
Archer is the third senior PRO at SB to leave gsk. SB corporate affairs
chief, James Hill, leaves within the next four months and Lynne Smith,
SB director and vice president of corporate communications - Europe and
international has recently accepted a redundancy package.